Panel Discussion: Balancing Commercial & Scientific Risk to Accelerate Commercialisation
- Outlining what large food companies are prioritising for innovative ingredients to align with their innovation pipelines
- Exploring ingredient and product cost dynamics through the lens of a strategic partnership, identifying where fermentation technologies have the most viability and competitive potential through life cycle analyses
- Discussing real-world collaborations where transformative R&D has complemented corporate goals